Covariate Pharmacokinetic Model Building in Oncology and its Potential Clinical Relevance
Open Access
- 25 January 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in The AAPS Journal
- Vol. 14 (1), 119-132
- https://doi.org/10.1208/s12248-012-9320-2
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Interpreting population pharmacokinetic‐pharmacodynamic analyses – a clinical viewpointBritish Journal of Clinical Pharmacology, 2011
- The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjectsJournal of Pharmacokinetics and Pharmacodynamics, 2010
- Population Pharmacokinetic-Pharmacogenetic Study of Nevirapine in HIV-Infected Cambodian PatientsAntimicrobial Agents and Chemotherapy, 2010
- Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithmJournal of Pharmacokinetics and Pharmacodynamics, 2009
- Population pharmacokinetic and pharmacogenetic analysis of 6‐mercaptopurine in paediatric patients with acute lymphoblastic leukaemiaBritish Journal of Clinical Pharmacology, 2008
- Population Pharmacokinetics and Pharmacogenetics of Imatinib in Children and AdultsClinical Cancer Research, 2008
- Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic–pharmacodynamic studyBritish Journal of Clinical Pharmacology, 2007
- Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipientsBritish Journal of Clinical Pharmacology, 2007
- Metrics for External Model Evaluation with an Application to the Population Pharmacokinetics of GliclazidePharmaceutical Research, 2006
- Determinants of the elimination of methotrexate and 7‐hydroxy‐methotrexate following high‐dose infusional therapy to cancer patientsBritish Journal of Clinical Pharmacology, 2005